Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Monteagudo-Gimeno, Eila
- dc.contributor.author Sánchez-González, Roberto
- dc.contributor.author Raduà Castaño, Joaquim
- dc.contributor.author Fortea-González, Lydia
- dc.contributor.author Boget Llucià, Teresa
- dc.contributor.author Carreño Martínez, Mar
- dc.contributor.author Donaire Pedraza, Antonio J.
- dc.contributor.author Bargalló Alabart, Núria
- dc.contributor.author Setoain Perego, Xavier
- dc.contributor.author Rumià Arboix, Jordi
- dc.contributor.author Bulbena Vilarrasa, Antonio
- dc.contributor.author Pintor-Pérez, Luis
- dc.date.accessioned 2024-10-21T06:46:26Z
- dc.date.available 2024-10-21T06:46:26Z
- dc.date.issued 2023
- dc.description.abstract Depressive/anxious disorders and cognitive impairment are frequent comorbidities in epilepsy and have a more deleterious effect in DRE. Studies concerning the relationship between anxiety and depression and cognitive performance in DRE are scarce. Higher scores in HADS are associated with lower QOLIE-31 scores and might be considered as predictors of QOL in DRE. A relationship between anxious and depressive symptoms -measured with HADS and SCL-90R- and cognition might not exist. There remains an unexplored study area regarding this relationship which requires more attention to improve the assessment of DRE.
- dc.format.mimetype application/pdf
- dc.identifier.citation Monteagudo-Gimeno E, Sánchez-González R, Raduà-Castaño J, Fortea-González L, Boget-Llucià T, Carreño-Martínez M, et al. Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy. Heliyon. 2023 Oct 14;9(10):e20903. DOI: 10.1016/j.heliyon.2023.e20903
- dc.identifier.doi http://dx.doi.org/10.1016/j.heliyon.2023.e20903
- dc.identifier.issn 2405-8440
- dc.identifier.uri http://hdl.handle.net/10230/68266
- dc.language.iso eng
- dc.publisher Elsevier
- dc.relation.ispartof Heliyon. 2023 Oct 14;9(10):e20903
- dc.rights © 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/
- dc.subject.other Epilèpsia
- dc.title Association between depressive and anxious symptoms with cognitive function and quality of life in drug-resistant epilepsy
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion